IP Library Granted Patent US 11,110,270
Granted Patent B2
US 11,110,270 · App. 15/576,670 · Granted Sep 7, 2021

Brain neurostimulator electrode fitting

Inventors: John Louis Parker (Artarmon, AU); Gerrit Eduard Gmel (Artarmon, AU)
Assignee: Closed Loop Medical Pty Ltd
A61N1/0534A61B5/24A61B5/377A61B5/6868A61N1/36067A61N1/36135A61N1/36185A61B5/4064A61B5/4082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,110,270
App. No.
15/576,670
Granted
Sep 7, 2021
Kind
B2
Abstract

Fitting a brain neurostimulator electrode array comprises positioning at least a first electrode in a desired target structure in a first cerebral hemisphere, and positioning at least a second electrode in a corresponding target structure in a contralateral cerebral hemisphere. Electrical stimuli are applied from the first electrode to the desired target structure. Neural responses observed at the second electrode in response to the electrical stimuli are recorded. The fitting of at least one of the first electrode and second electrode is assessed by reference to the recorded neural responses.

Claims (41)

1. A method of fitting a brain neurostimulator electrode array, the method comprising:

positioning at least a first electrode in a desired target structure in a first ipsilateral cerebral hemisphere;

positioning at least a second electrode in a corresponding target structure in a second contralateral cerebral hemisphere;

applying an ipsilateral electrical stimuli from the first electrode to the desired target structure in the first ipsilateral cerebral hemisphere;

recording evoked compound action potentials observed in the second contralateral cerebral hemisphere at the second electrode in response to the electrical stimuli;

processing evoked compound action potentials observed at the second electrode so as to determine at least one of a presence, an amplitude, a morphology, and a latency of the evoked compound action potentials observed at the second electrode; and

assessing the fitting of at least one of the first electrode and second electrode by reference to the recorded evoked compound action potential.

2. The method of claim 1 wherein the neurostimulator comprises a deep brain stimulator.

3. The method of claim 2 wherein the target structure comprises a subthalamic nucleus.

4. The method of claim 1 wherein the first electrode is fitted by reference to the recorded evoked compound action potentials by seeking a maxima in the recorded evoked compound action potentials.

5. The method of claim 4 , wherein the first electrode is progressively relocated intra-operatively while observing an amplitude of the evoked compound action potentials observed at the second electrode to seek a maxima in the recorded evoked compound action potentials.

6. The method of claim 1 wherein the second electrode is fitted by reference to the recorded evoked compound action potentials by seeking a maxima in the recorded evoked compound action potentials.

7. The method of claim 1 wherein the fitting comprises intra-operative electrode positioning.

8. The method of claim 7 , wherein the first electrode and second electrode are intra-operatively implanted to respective approximate locations using stereotaxy, before the step of assessing the fitting.

9. The method of claim 1 further comprising:

applying further electrical stimuli from the second electrode to the corresponding target structure in the contralateral cerebral hemisphere;

recording, with the first electrode, further contralateral evoked compound action potentials from the target structure; and

assessing the fitting of at least one of the first electrode and second electrode by reference to the recorded further contralateral responses.

10. The method of claim 1 wherein the fitting comprises post-operative electrode selection.

11. The method of claim 1 wherein assessing the fitting comprises comparing a current fitting to a past fitting so as to monitor the fitting for changes over time.

12. A brain neurostimulator device comprising:

at least a first electrode configured to be positioned in a desired target structure in a first ipsilateral cerebral hemisphere;

at least a second electrode configured to be positioned in a corresponding target structure in a second contralateral cerebral hemisphere;

a pulse generator configured to apply an ipsilateral electrical stimuli from the first electrode to the desired target structure in the first ipsilateral cerebral hemisphere;

measurement circuitry configured to record evoked compound action potentials observed in the second contralateral cerebral hemisphere at the second electrode in response to the electrical stimuli; and

a processor configured to process the evoked compound action potentials observed at the second electrode so as to determine at least one of a presence, an amplitude, a morphology, and a latency of the evoked compound action potentials observed at the second electrode, and further configured to assess the fitting of at least one of the first electrode and second electrode by reference to the recorded evoked compound action potentials.

13. The brain neurostimulator device of claim 12 wherein the neurostimulator comprises a deep brain stimulator.

14. The brain neurostimulator device of claim 13 wherein the electrodes are configured to be positioned in the subthalamic nucleus.

15. The brain neurostimulator device of claim 12 wherein the processor is configured to fit the first electrode by seeking a maxima in the recorded evoked compound action potentials.

16. The brain neurostimulator device of claim 12 wherein the processor is configured to fit the second electrode by seeking a maxima in the recorded evoked compound action potentials.

17. The brain neurostimulator device of claim 12 wherein the processor is configured to provide intra-operative electrode positioning.

18. The brain neurostimulator device of claim 12 wherein the processor is further configured to:

apply further electrical stimuli from the second electrode to the corresponding target structure in the contralateral cerebral hemisphere;

record, with the first electrode, further contralateral evoked compound action potentials from the target structure; and

assess the fitting of at least one of the first electrode and second electrode by reference to the recorded further contralateral evoked compound action potentials.

19. The brain neurostimulator device of claim 12 wherein the processor is configured to provide post-operative electrode selection.

20. The brain neurostimulator device of claim 12 wherein the processor is configured to assess the fitting by comparing a current fitting to a past fitting so as to monitor the fitting for changes over time.

21. A non-transitory computer readable medium for fitting a brain neurostimulator electrode array, the computer readable medium comprising computer program code means for applying electrical stimuli from a first electrode positioned in a desired target structure in a first ipsilateral cerebral hemisphere, to the desired target structure;

computer program code means for recording evoked compound action potentials observed at a second electrode in a corresponding target structure in a second contralateral cerebral hemisphere in response to the electrical stimuli;

computer program code means for processing the evoked compound action potentials observed at the second electrode so as to determine at least one of a presence, an amplitude, a morphology, and a latency of the evoked compound action potentials observed at the second electrode; and

computer program code means for assessing the fitting of at least one of the first electrode and second electrode by reference to the recorded evoked compound action potentials.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: SALUDA MEDICAL PTY LTD
To: CLOSED LOOP MEDICAL PTY LTD
Reel/Frame 054354/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2017
From: PARKER, JOHN LOUIS; GMEL, GERRIT EDUARD
To: SALUDA MEDICAL PTY LTD
Reel/Frame 044202/0763 →
Priority Claims (1)
AU 2015902021 · May 31, 2015 · national
Continuity (1)
Related Publication 20180133459A1 · May 17, 2018
Cited By (3)
US 12,285,263 US 12,329,527 US 12,376,780